SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-008013
Filing Date
2024-01-16
Accepted
2024-01-16 06:05:29
Documents
12
Period of Report
2024-01-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d699758d8k.htm   iXBRL 8-K 21509
  Complete submission text file 0001193125-24-008013.txt   146055

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vinc-20240112.xsd EX-101.SCH 2839
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20240112_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20240112_pre.xml EX-101.PRE 11700
6 EXTRACTED XBRL INSTANCE DOCUMENT d699758d8k_htm.xml XML 3468
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 24533518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)